Experienced in Cerebellar Multiple System Atrophy

Dr. Lorraine J. Spikol

Neurology | Psychiatry
Lehigh Valley Physician Group
1200 S Cedar Crest Blvd, 
Allentown, PA 
Experienced in Cerebellar Multiple System Atrophy
Lehigh Valley Physician Group
1200 S Cedar Crest Blvd, 
Allentown, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Lorraine Spikol is a Neurologist and a Psychiatrist in Allentown, Pennsylvania. Dr. Spikol is rated as an Experienced provider by MediFind in the treatment of Cerebellar Multiple System Atrophy. Her top areas of expertise are Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Supranuclear Ocular Palsy, and Progressive Supranuclear Palsy Atypical.

Her clinical research consists of participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Psychiatry
Licenses
Psychiatry & Neurology in PA
Hospital Affiliations
Lehigh Valley Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

LEHIGH VALLEY PHYSICIAN GROUP
1200 S Cedar Crest Blvd, Allentown, PA 18103
Other Locations
LEHIGH VALLEY PHYSICIAN GROUP
2545 Schoenersville Rd, Bethlehem, PA 18017

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Long-Term Nicotine Treatment of Mild Cognitive Impairment
Long-Term Nicotine Treatment of Mild Cognitive Impairment
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Drug
Study Drug: Nicotine Transdermal Patch
Study Phase: Phase 2
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Drug
Study Phase: Phase 2
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Enrollment Status: Terminated
Publish Date: April 19, 2021
Intervention Type: Drug
Study Phase: Phase 2
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
Enrollment Status: Terminated
Publish Date: December 03, 2019
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease
A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: October 10, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
Advanced in Cerebellar Multiple System Atrophy
Dr. Fred M. Weinblatt
Neurology
Advanced in Cerebellar Multiple System Atrophy
Dr. Fred M. Weinblatt
Neurology

Penn Neuroscience Center - Neurology

3400 Civic Center Boulevard, South Pavilion, 2nd Floor, 
Philadelphia, PA 
 (46.2 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Fred Weinblatt is a Neurologist in Philadelphia, Pennsylvania. Dr. Weinblatt is rated as a Distinguished provider by MediFind in the treatment of Cerebellar Multiple System Atrophy. His top areas of expertise are Memory Loss, Cerebellar Degeneration, Lewy Body Dementia (LBD), and Cerebellar Multiple System Atrophy. Dr. Weinblatt is currently accepting new patients.

Advanced in Cerebellar Multiple System Atrophy
Dr. David J. Irwin
Neurology
Advanced in Cerebellar Multiple System Atrophy
Dr. David J. Irwin
Neurology

Penn Neuroscience Center - Neurology

3400 Civic Center Boulevard, South Pavilion, 2nd Floor, 
Philadelphia, PA 
 (46.2 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Irwin is a Neurologist in Philadelphia, Pennsylvania. Dr. Irwin is rated as an Elite provider by MediFind in the treatment of Cerebellar Multiple System Atrophy. His top areas of expertise are Frontotemporal Dementia, Lewy Body Dementia (LBD), Dementia, and Corticobasal Degeneration. Dr. Irwin is currently accepting new patients.

Advanced in Cerebellar Multiple System Atrophy
Dr. Sanjeev Vaishnavi
Neurology
Advanced in Cerebellar Multiple System Atrophy
Dr. Sanjeev Vaishnavi
Neurology

Penn Memory Center

3400 Civic Center Boulevard, South Pavilion, 2nd Floor, 
Philadelphia, PA 
 (46.2 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sanjeev Vaishnavi is a Neurologist in Philadelphia, Pennsylvania. Dr. Vaishnavi is rated as a Distinguished provider by MediFind in the treatment of Cerebellar Multiple System Atrophy. His top areas of expertise are Lewy Body Dementia (LBD), Cerebellar Degeneration, Memory Loss, and Dementia. Dr. Vaishnavi is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Spikol's expertise for a condition
ConditionClose
      View All 18 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile